By Associate Professor Min Jun

Journal articles

Wallace H; Wang Q; Simoni K; Jun M; Crikis S; Nelson C, 2026, 'Evaluation of a nurse-led chronic kidney disease clinic: a single centre cohort study', Clinical Kidney Journal, http://dx.doi.org/10.1093/ckj/sfag084

Imenez Silva PH; Jun M; Zacchia M; Trepiccione F; Capasso G, 2026, 'Embracing good practices of confirmatory studies.', Kidney Blood Press Res, pp. 1 - 4, http://dx.doi.org/10.1159/000551239

Wallace H; Buizen L; Badve SV; Ha JT; Ketema DB; Ronksley P; Sasaki T; Siriwardana A; Harris K; Henry A; Woodward M; Kotwal SS; Jun M, 2026, 'Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset', Diabetes Obesity and Metabolism, 28, pp. 2329 - 2338, http://dx.doi.org/10.1111/dom.70428

Chatur S; Fletcher RA; Yeung E; Siriwardana A; Heath L; Vaduganathan M; Arnott C; Badve SV; Kotwal S; Jun M; Jardine M; Pollock C; Heerspink HJ; Perkovic V; Neuen BL, 2026, 'SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2.', J Card Fail, http://dx.doi.org/10.1016/j.cardfail.2026.01.020

Badve SV; Al Ammari M; Anderson CS; Billot L; Bompoint S; Collister D; De Vriese AS; Eikelboom JW; Flahault A; Garg AX; Ha JT; Heerspink HJL; Jardine MJ; Jesudason S; Jha V; Jun M; Landrigan J; Liew A; Lin E; Lv J; Mark PB; Menne J; Monaghan H; Mushahar L; Patel A; Pilmore H; Perkovic V; Ramachandran R; Rossignol P; Shaman A; Skhiri H; Walsh M; Wheeler DC; Wong MG; Zuo L; Gallagher M, 2026, 'Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.', Am J Nephrol, pp. 1 - 11, http://dx.doi.org/10.1159/000550796

Ketema DB; Joshi R; Hailu W; Gallagher M; Kotwal S; Jun M, 2026, 'Availability and readiness of health facilities for chronic kidney disease, diabetes and cardiovascular disease in Ethiopia: Evidence from service provision assessment data', Diabetes Obesity and Metabolism, 28, pp. 960 - 971, http://dx.doi.org/10.1111/dom.70268

Wallace H; Abdy ME; Anderson K; Johns E; Nguyen T; Scuderi C; Lee V; Tunnicliffe DJ; Jun M; See E; Brown L; Coolican H; Craig J; Cullen V; Ha J; Krishnasamy R; Lambert K; Light C; O'Neill E; Smith H; Viecelli A, 2026, 'Caring for Australians and New Zealanders with kidney Impairment guidelines commentary on the Kidney Disease: Improving Global Outcomes clinical practice guideline for management of diabetes and chronic kidney disease', Internal Medicine Journal, 56, pp. 274 - 279, http://dx.doi.org/10.1111/imj.70317

Sasaki T; Buizen L; Harris K; Badve SV; Chalmers J; Gallagher M; Ha JT; Jardine MJ; Ketema DB; Kotwal SS; Neuen BL; Ronksley PE; Wallace H; Yokoo T; Woodward M; Jun M, 2026, 'Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset', Kidney360, 7, pp. 312 - 320, http://dx.doi.org/10.34067/KID.0000000988

HA JT; FLETCHER RA; ARNOTT C; JUN M; KOTWAL SS; PERKOVIC V; BADVE SV; NEUEN BL, 2026, 'Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level Pooled Analysis from the CANVAS Program and CREDENCE Trial', Journal of Cardiac Failure, 32, pp. 151 - 156, http://dx.doi.org/10.1016/j.cardfail.2025.05.021

Yeung E; Siriwardana A; Buizen L; Tang A; Heath L; Jun M; Tang S; Kotwal S; Arnott C; Levin A; Jardine M; Mahaffey K; Perkovic V; Heerspink H; Neuen B, 2026, 'WCN26-2797 Impact of Polypharmacy on the Efficacy and Safety of SGLT2 Inhibitors in Patients with Chronic Kidney Disease: Insights from the CREDENCE trial', Kidney International Reports, 11, pp. 104597 - 104597, http://dx.doi.org/10.1016/j.ekir.2026.104597

Hill J; Motshwari D; Yakubu K; Saluja D; Okpechi I; Kengne A; Woodward M; Jun M; Kotwal S; George C, 2026, 'WCN26-2801 EXPLORING CULTURAL SAFETY AND EQUITY IN CHRONIC KIDNEY DISEASE CARE ACROSS AFRICA: PROTOCOL FOR A MULTI-COUNTRY QUALITATIVE INQUIRY', Kidney International Reports, 11, pp. 105998 - 105998, http://dx.doi.org/10.1016/j.ekir.2026.105998

Tang HCA; Yeung EK; Siriwardana A; Buizen L; Tang SCW; Jun M; Kotwal S; Arnott C; Cherney DZI; Neal B; Perkovic VP; Heerspink HJL; Neuen BL, 2026, 'WCN26-7232 EFFECTS OF CANAGLIFLOZIN ON BETA-CELL FUNCTION AND INSULIN RESISTANCE IN TYPE 2 DIABETES MELLITUS: DATA FROM THE CANVAS TRIAL', Kidney International Reports, 11, pp. 104640 - 104640, http://dx.doi.org/10.1016/j.ekir.2026.104640

Yamaguchi Y; Kosugi T; Sasaki T; Haruhara K; Okabayashi Y; Okabe M; Shimizu A; Yokote S; Kotwal S; Jun M; Neuen BL; Tsuruya K; Ueda H; Tsuboi N; Yokoo T, 2025, 'The Association between Low-Grade Proteinuria and Adverse Kidney Outcomes in IgA Nephropathy: A Systematic Review and Meta-Analysis.', Clin J Am Soc Nephrol, http://dx.doi.org/10.2215/CJN.0000000952

Wallace H; Daly JO; Jun M; Nelson C, 2025, 'Rethinking Models of Chronic Kidney Disease Care: A Narrative Review', Kidney and Blood Pressure Research, 50, pp. 433 - 441, http://dx.doi.org/10.1159/000546562

Lam D; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M; Ha JT, 2025, 'Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation', Kidney360, 6, pp. 1510 - 1521, http://dx.doi.org/10.34067/KID.0000000809

Chatur S; Heath L; Fletcher RA; Arnott C; Badve SV; Kotwal S; Vaduganathan M; Jun M; Jardine M; Heerspink H; Perkovic V; Neuen B, 2025, 'Canagliflozin in patients with type 2 Diabetes and CKD experiencing deterioration in eGFR to &lt;20 ml/min/1.73m2 in the CREDENCE Trial', European Heart Journal, 46, http://dx.doi.org/10.1093/eurheartj/ehaf784.4190

Ketema DB; Jun M; Kotwal S; Hailu W; Gallagher M; Joshi R, 2025, 'Stakeholders' perspectives on barriers and enablers of chronic kidney disease care in Ethiopia: A qualitative study', Plos One, 20, http://dx.doi.org/10.1371/journal.pone.0336781

Li AK; Kotwal S; Wallace H; Ketema DB; Wick J; Neuen BL; Falster MO; Lin J; Pearson SA; Peiris D; Jardine MJ; Woodward M; Chalmers J; Ronksley PE; Jun M, 2025, 'Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset', BMJ Open, 15, pp. e096730 - e096730, http://dx.doi.org/10.1136/bmjopen-2024-096730

Davis G; Kim D; Jun M; Kotwal SS, 2025, 'Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management', Heart Lung and Circulation, 34, pp. 1060 - 1068, http://dx.doi.org/10.1016/j.hlc.2025.05.095

Wallace H; Wick J; Neuen BL; Buizen L; Badve SV; Chalmers J; de Oliveira Costa J; Falster MO; Ha JT; Jardine MJ; Ketema DB; Lin J; Nelson C; Pearson SA; Peiris D; Rodgers A; Sasaki T; Woodward M; Gallagher M; Kotwal SS; Ronksley P; Jun M, 2025, 'Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset', Diabetes Obesity and Metabolism, 27, pp. 5599 - 5611, http://dx.doi.org/10.1111/dom.16608

Ketema DB; Wallace H; Hailu W; Badve SV; Ronksley P; Neuen BL; Pecoits-Filho R; Gallagher M; Kotwal S; Perkovic V; Joshi R; Jun M, 2025, 'Quality of care for people with chronic kidney disease: a systematic review and meta-analysis', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2025-102044

Bose B; Carter SA; Abdy ME; Scholes-Robertson N; Roberts I; Goh TL; Lee V; See E; Coolican H; Cullen V; Jun M; Krishnasamy R; Lambert K; Craig J; Light C; Nguyen T; Scuderi C; Tunnicliffe DJ; Viecelli AK, 2025, 'CARI Guidelines Commentary on the KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases', Nephrology, 30, http://dx.doi.org/10.1111/nep.70119

MILDER TY; SHEPHERD L; PEARSON S-A; KRISTIAN RÅKET H; GREENFIELD J; DAY RO; LIN J; POLLOCK CA; NEUEN B; JUN MIN; DE OLIVEIRA COSTA J; STOCKER S; LUDINGTON J; FALSTER MO, 2025, '904-P: Hospitalization Is a Risk Factor for SGLT2i Discontinuation', Diabetes, 74, http://dx.doi.org/10.2337/db25-904-p

Lin J; Milder TY; Deakin CT; de Oliveira Costa J; Havard A; Neuen BL; Buckley NA; Brieger D; Greenfield JR; Jun M; Day RO; Pearson SA; Falster MO, 2025, 'Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study', Diabetes Research and Clinical Practice, 224, pp. 112242, http://dx.doi.org/10.1016/j.diabres.2025.112242

Zhu Y; Jun M; Fletcher RA; Arnott C; Neuen BL; Kotwal SS, 2025, 'Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial', Diabetes Obesity and Metabolism, 27, pp. 3531 - 3535, http://dx.doi.org/10.1111/dom.16363

Wallace H; Wick J; Ketema DB; Buizen L; Woodward M; Peiris D; Neuen BL; Robertson C; Nelson C; Chalmers J; Badve SV; Kotwal SS; Ronksley P; Gallagher M; Jun M, 2025, 'Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset', Lancet Regional Health Western Pacific, 57, http://dx.doi.org/10.1016/j.lanwpc.2025.101541

Siriwardana A; Buizen L; Jun M; Kotwal S; Arnott C; Jardine MJ; Levin A; Heerspink HJL; Charytan DM; Pollock C; Perkovic V; Neuen BL, 2025, 'Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial', Diabetes Obesity and Metabolism, 27, pp. 1972 - 1979, http://dx.doi.org/10.1111/dom.16190

Chan B; Varghese A; Badve SV; Pecoits-Filho R; Guedes M; Arnott C; Kozor R; O'Lone E; Jun M; Kotwal S; Block GA; Chertow GM; Solomon SD; Vaduganathan M; Perkovic V; Neuen BL, 2025, 'Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD', Kidney International Reports, 10, pp. 1037 - 1049, http://dx.doi.org/10.1016/j.ekir.2025.01.029

Feng Y; Jun M; Wang AY; Ren S; Weisbord SD; Bellomo R; Ostermann M; Arnott C; Gallagher M, 2025, 'Predicting Contrast-Associated Acute Kidney Injury', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.0107

Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2025, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes Obesity and Metabolism, 27, pp. 997 - 1000, http://dx.doi.org/10.1111/dom.16061

Kim D; Lee J; Toyama T; Liyanage T; Woodward M; Matsushita K; Hooi LS; Lin MY; Iseki K; Jha V; Wong MG; Jun M, 2025, 'Prevalence and Treatment Patterns of Anaemia in Individuals With Chronic Kidney Disease Across Asia: A Systematic Review and Meta-Analysis', Nephrology, 30, http://dx.doi.org/10.1111/nep.70002

See EJ; Cullen V; Krishnasamy R; Boag J; Coolican H; Craig J; Fortnum D; Guha C; Howell M; Johnston B; Jun M; Lambert K; Lee V; Nguyen T; Scuderi C; Tunnicliffe D; Viecelli A; Walker R; Chiekh Hassan HI; Light C, 2025, 'Commentary on the 2021 update of the KDIGO clinical practice guideline for management of blood pressure in chronic kidney disease', Nephrology, 30, http://dx.doi.org/10.1111/nep.14414

Ketema DB; Buizen L; Wallace H; Ha JTK; Neuen BL; Sasaki T; Jardine M; Kotwal SS; Kosugi T; Ronksley PE; Woodward M; Jun M, 2025, 'Incidence of CKD in Australian Primary Care: Analysis of a National Primary Care Dataset', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025fcqchx75

Ha J; Buizen L; Wallace H; Ketema D; Sasaki T; Arnott C; Badve S; Costa J; Falster M; Gallagher M; Milder T; Pearson S; Kotwal S; Ronksley P; Woodward M; Neuen B; Jun M, 2025, 'Prevalence, Overlap, and Treatment of Cardiovascular-Kidney-Metabolic Conditions in Australian Primary Care: Estimates From a National General Practice Dataset', Heart, Lung and Circulation, 34, pp. S529 - S529, http://dx.doi.org/10.1016/j.hlc.2025.06.676

Sasaki T; Buizen L; Harris K; Badve S; Chalmers JP; Gallagher MP; Ha JTK; Jardine M; Ketema DB; Kotwal SS; Neuen BL; Ronksley PE; Wallace H; Yokoo T; Woodward M; Jun M, 2025, 'Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025wn84xd9r

Ketema D; Joshi R; Kotwal S; Hailu W; Gallager M; Jun M, 2025, 'WCN25-1537 ASSESSING THE EPIDEMIOLOGY OF CHRONIC KIDNEY DISEASE IN ETHIOPIA USING A POPULATION-BASED NATIONAL ADMINISTRATIVE DATA SOURCE', Kidney International Reports, 10, pp. S287 - S287, http://dx.doi.org/10.1016/j.ekir.2024.11.534

Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, 84, pp. 2246 - 2250, http://dx.doi.org/10.1016/j.jacc.2024.08.006

Ha JT; Hiremath S; Jun M; Green SC; Wheeler DC; Coyne DW; Perkovic V; Badve SV, 2024, 'Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease', Nejm Evidence, 3, http://dx.doi.org/10.1056/EVIDoa2300189

Cashmore B; Tunnicliffe DJ; Palmer S; Blythen L; Boag J; Kostner K; Krishnasamy R; Lambert K; Miller A; Mullan J; Patu M; Phoon RKS; Rix L; Trompf N; Johnson DW; Walker R; Lee V; Boag J; Coolican H; Cullen V; Fortnum D; Hassan H; Jun M; Craig J; Light C; Nguyen T; Palmer S; Scuderi C; See E; Viecelli A; Walker R, 2024, 'Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gap', Nephrology, 29, pp. 495 - 509, http://dx.doi.org/10.1111/nep.14295

Maeda T; Woodward M; Jun M; Sakamoto Y; Chen X; Matsushita K; Mancia G; Arima H; Anderson CS; Chalmers J; Harris K, 2024, 'Risk of recurrent stroke and dementia following acute stroke by changes in kidney function: results from the Perindopril Protection Against Recurrent Stroke Study', Journal of Hypertension, 42, pp. 1313 - 1321, http://dx.doi.org/10.1097/HJH.0000000000003711

Scholes-Robertson N; Guha C; Gutman T; Howell M; Yip A; Cashmore B; Roberts I; Lopez-Vargas P; Wong G; MacGinley R; Synnot A; Craig JC; Jauré A; Krishnasamy R; Tunnicliffe DJ; Lee V; Boag J; Coolican H; Cullen V; Fortnum D; Hassan H; Jun M; Lambert K; Light C; Nguyen T; Palmer S; Scuderi C; See E; Viecelli A; Walker R, 2024, 'Consumer involvement in the development and dissemination of chronic kidney disease guidelines: a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines', Journal of Clinical Epidemiology, 170, http://dx.doi.org/10.1016/j.jclinepi.2024.111330

Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV, 2024, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, 83, pp. 350 - 359.e1, http://dx.doi.org/10.1053/j.ajkd.2023.07.023

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', Lancet Regional Health Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Ketema DB; Wallace H; Neuen BL; Kotwal SS; Ronksley PE; Badve S; Perkovic V; Gallagher MP; Joshi R; Jun M, 2024, 'Assessing the Quality of Care for People with CKD: A Systematic Review and MetaAnalysis', JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35, http://dx.doi.org/10.1681/ASN.2024bzcfkb63

Siriwardana A; Jardine M; Perkovic V; Jun M; Kotwal SS; Arnott CG; Neuen BL, 2024, 'Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial', JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35, http://dx.doi.org/10.1681/ASN.2024e59ygyz9

Yeung EK; Ferguson TW; Tangri N; Vaduganathan M; Arnott CG; Jun M; Kotwal SS; Jardine M; Perkovic V; Heerspink HJL; Neuen BL, 2024, 'Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial', JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35, http://dx.doi.org/10.1681/ASN.2024k6fn2ax5

Wallace H; Wick J; Ketema DB; Neuen BL; Jardine M; Lin J; Nelson CL; Pearson S; Peiris D; Woodward M; Ronksley PE; Gallagher MP; Kotwal SS; Jun M, 2024, 'Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status', Journal of the American Society of Nephrology, 35, pp. 10.1681/asn.2024f7q40fk1, http://dx.doi.org/10.1681/asn.2024f7q40fk1

Ha J; Hiremath S; Jun M; Palmer S; Wheeler D; Coyne D; Perkovic V; Badve S, 2024, 'WCN24-2313 LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS', Kidney International Reports, 9, pp. S562 - S563, http://dx.doi.org/10.1016/j.ekir.2024.02.1183

Colombijn JMT; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RWM, 2023, 'Antioxidants for adults with chronic kidney disease', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD008176.pub3

Back to profile page